Variables | ATS+ (n = 24) | ATS-(n = 51) | p |
---|---|---|---|
Age (years) | 60.4 ± 11.0 | 47.8 ± 14.4 | < 0.0001 |
Female age ≥ 55 years,n (%) | 15 (75.0) | 16 (40.0) | 0.010 |
Male age ≥ 45 years,n (%) | 4 (100.0) | 10 (55.6) | 0.137 |
Established RA, n (%) | 15 (62.5) | 42 (82.4) | 0.005 |
Median duration of RA (years) | 2 (0.3–12.0) | 2 (0.2–12.0) | 0.850 |
DAS28-ESR > 2,6 n (%) | 23 (95.8) | 39 (76.5) | >0.034 |
Severe RA, n (%) | 18 (66.7) | 29 (56.9) | 0.029 |
Dose of MTX, mg/week | 7.8 ± 1.5 | 8.5 ± 2.2 | 0.153 |
Duration of corticosteroid use, month, median (extremes) | 1 (1.0–6.0) | 2 (0.5–12.0) | 0.975 |
Heart rate, bpm | 81.1 ± 15.2 | 81.3 ± 10.2 | 0.949 |
SBP, mmHg | 137.9 ± 19.4 | 125.3 ± 19.5 | 0.010 |
DBP, mmHg | 79.1 ± 9.4 | 77.2 ± 10.8 | 0.447 |
PP, mmHg | 58.3 ± 18.7 | 49.9 ± 14.2 | 0.034 |
Waist cicumference, cm | 94.9 ± 11.3 | 86.7 ± 11.8 | 0.006 |
BMI, Kg/m2 | 26.7 ± 4.9 | 22.7 ± 4.2 | 0.001 |
HBP, n (%) | 14 (58.3) | 7 (13.7) | < 0.0001 |
Diabetes mellitus, n (%) | 7 (29.2) | 3 (5.9) | 0.010 |
Physical inactivity, n (%) | 19 (79.2) | 22 (43.1) | 0.003 |
Alcoholism, n (%) | 8 (33.3) | 13 (25.5) | 0.330 |
Tobacco use, n (%) | 1 (4.2) | 1 (2.0) | 0.541 |
Global Obesity, n (%) | 8 (33.3) | 1 (2.0) | < 0.0001 |
Overweight, n (%) | 9 (37.5) | 13 (25.5) | 0.212 |
PP > 60 mmHg, n (%) | 7 (29.2) | 15 (29.4) | 0.603 |
Metabolic syndrome, n (%) | 9 (37.5) | 10 (19.6) | 0.008 |
Low HDL-c, n (%) | 7 (29.2) | 13 (25.5) | 0.471 |
Hypertriglyceridemia, n (%) | 16 (66.7) | 20 (39.2) | 0.024 |
Hypercholesterolemia, n (%) | 19 (79.2) | 31 (60.8) | 0.009 |
High LDL-c,n (%) | 18 (75.0) | 35 (68.6) | 0.390 |
Glycaemia,mg/dl | 85.1 ± 22.4 | 83.7 ± 21.6 | 0.798 |
RF+, n (%) | 8 (33.3) | 24 (47.1) | 0.192 |
ESR,mm/h1,median (extremes) | 40.5 (8–115) | 40.0 (13–145) | 0.866 |
CRP, median (extremes) | 24.0 (6–72) | 21 (6–72) | 0.775 |